Petros Pharmaceuticals Files 8-K
Ticker: PTPI · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1815903
| Field | Detail |
|---|---|
| Company | Petros Pharmaceuticals, Inc. (PTPI) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
Related Tickers: PETS
TL;DR
PETS filed an 8-K, check for updates.
AI Summary
Petros Pharmaceuticals, Inc. filed an 8-K on June 20, 2025, reporting an event on June 16, 2025. The filing is a current report under Regulation FD and includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in New York, NY.
Why It Matters
This 8-K filing indicates a regulatory disclosure event for Petros Pharmaceuticals, Inc., which may contain important updates for investors.
Risk Assessment
Risk Level: low — This filing is a standard 8-K current report and does not appear to contain immediately concerning information.
Key Players & Entities
- Petros Pharmaceuticals, Inc. (company) — Registrant
- June 16, 2025 (date) — Earliest event reported
- June 20, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- New York, New York (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a current report under Regulation FD and includes financial statements and exhibits for Petros Pharmaceuticals, Inc.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on June 16, 2025.
What is the filing date of this 8-K?
This 8-K was filed on June 20, 2025.
Where are the principal executive offices of Petros Pharmaceuticals, Inc. located?
The principal executive offices of Petros Pharmaceuticals, Inc. are located at 1185 Avenue of the Americas, 3rd Floor, New York, New York 10036.
In which state is Petros Pharmaceuticals, Inc. incorporated?
Petros Pharmaceuticals, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Petros Pharmaceuticals, Inc. (PTPI).